Hannah Tandon
ORCID: 0000-0002-2522-7979
· 9 papers in corpus
rct
2026
BACKGROUND: Chronic pelvic pain affects one in four women. Botulinum toxin, approved for chronic migraine and cervical dystonia pain, is an emerging treatment for other pain conditions. We evaluated intramuscular pelvic floor botulinum toxi…
rct
2022
Abstract Pelvic pain persists despite standard care in about 30% of women with a history of endometriosis and pain. Pelvic pain may be accompanied by spasm in pelvic floor muscles that results in sexual pain, impairs intimacy, and might con…
2021
observational
2020
BACKGROUND: Chronic pelvic pain persists in some women with endometriosis even after lesion removal and optimized hormonal treatment. OBJECTIVE: Characterize the presence and distribution of pain, myofascial dysfunction and sensitisation b…
other
2019
BACKGROUND AND OBJECTIVES: Many women with endometriosis continue to have pelvic pain despite optimal surgical and hormonal treatment; some also have palpable pelvic floor muscle spasm. We describe changes in pain, spasm, and disability aft…
2019
2018
Assess effects of botulinum toxin for chronic pelvic pain in endometriosis.
observational
2018
To assess myofascial dysfunction and sensitization beyond the pelvis in women with endometriosis-associated chronic pelvic pain (endo-CPP).
2018